Pluri (PLUR) Common Equity (2011 - 2025)
Pluri (PLUR) reported Common Equity of -$14.6 million for Q4 2025, down 400.79% year-over-year from $4.9 million in Q4 2024, and down 158.69% quarter-over-quarter from -$5.6 million in Q3 2025.
Pluri (PLUR) Common Equity (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Common Equity data on file, last reported at -$14.6 million in Q4 2025.
- Common Equity for Q4 2025 came in at -$14.6 million, down 400.79% year-over-year; the trailing twelve-month figure through Dec 2025 was -$14.6 million (down 400.79% YoY), and the FY2025 annual result was -$865000.0, down 115.97% from the prior year.
- Common Equity eased to -$14.6 million in Q4 2025 per PLUR's latest filing, from -$5.6 million in the prior quarter.
- Over five years, Common Equity peaked at $68.1 million in Q1 2021 and troughed at -$14.6 million in Q4 2025.
- A 5-year average of $18.8 million and a median of $13.2 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2025: Common Equity jumped 380.88% in 2021, then plunged 8863.49% in 2025.
- A 5-year view of Common Equity shows it stood at $39.8 million in 2021, then slumped by 37.33% to $25.0 million in 2022, then tumbled by 73.5% to $6.6 million in 2023, then sank by 144.08% to -$2.9 million in 2024, then tumbled by 400.79% to -$14.6 million in 2025.
- Business Quant data shows PLUR's Common Equity at -$14.6 million in Q4 2025, -$5.6 million in Q3 2025, and -$865000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -14.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.61 Mn |
| Sep 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -865,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | -2.92 Mn |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 6.62 Mn |
| Sep 30, 2023 | 11.04 Mn |
| Jun 30, 2023 | 15.30 Mn |
| Mar 31, 2023 | 20.88 Mn |
| Dec 31, 2022 | 24.97 Mn |
| Sep 30, 2022 | 26.90 Mn |
| Jun 30, 2022 | 32.19 Mn |
| Mar 31, 2022 | 40.14 Mn |
| Dec 31, 2021 | 39.84 Mn |
| Sep 30, 2021 | 48.91 Mn |
| Jun 30, 2021 | 57.15 Mn |
| Mar 31, 2021 | 68.14 Mn |